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A straight forward synthesis of 4-arylidene-2-phenyl-5(4H)-oxazolones (also called azlactones) by the condensation of 
arylaldehyde with hippuric acid in the presence of acetic anhydride and zinc dust as aheterogeneous catalyst is described. 
The reaction proceeds rapidly, does not require any additives and has a significantly shorter reaction rate. In the present 
method, aromatic aldehydes and hippuric acid have been successfully applied to synthesize various substituted azlactones in 
good to excellent yields. The final product has been characterised by FT-IR, 1H and 13C NMR, and mass spectrometry. 
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Heterocyclic molecules found in nature and synthetic 
proven breakthrough in biological activities and are 
essential in human life. In a broad classification of 
heterocyclic compounds available, azlactone 
heterocyclic compound exhibited vast range of 
pharmacological applications1 (Figure 1). The 
molecule has five membered heterocyclic nucleus 
containing nitrogen and oxygen as heteroatom in their 
structural skeleton, which is one of the important 
classes of heterocycles. The literature data revealed 
that, position C-2 and C-4 of the azlactones are 
important and played important role in biological 
activities. Azlactone nucleus containing heterocyclic 
molecules found important pharmacological 
applications such as analgesic2, anti-microbial, anti 
tumour3, anti-bacterial4, anti-fungal5, anti-cancer6, 
anti-inflammation7, anti-HIV8, anti-diabetic9, anti-
obesit10, biosensors, photosensitive composition 
devices for proteins11, tyrosinase inhibitory12, in 
treatment of skin diseases13, neuroleptic 
applications14, photochemical and photophysical and 
as pH sensors15. Further, azlactones are found 
important intermediates in the synthesis of various 
organic motifs, including amino acids16, peptides17, α-
acylamino alcohols, thiamine, N-substituted pyrroles, 
amides and other hetero aromatic molecules18, and 
used in various alkaloid skeleton construction. 
Azlactone synthesis also called Erlenmeyer reaction 
first discovered in 1893 by Emil Erlenmeyer who 
demonstrated the reaction of benzaldehyde with 
hippuric acid in presence of acetic anhydride (Ac2O) 
and sodium acetate as dehydrating and base catalyst 
respectively19. Subsequently, Erlenmeyer established 
the structure of azlactone using spectroscopic 
techniques and named it as an azlactone. 
The reaction proceeds via a Perkin condensation 
through initial cyclization of hippuric acid gave the 
product Erlenmeyer azlactones. The organic synthesis 
promoted by the catalyst is one of the hot areas of 
research in the present days. In literature vast number 
of catalyst have been reported for the synthesis of 
azlactones are polyphosphoric acid20, perchloric 
acid21, POCl322, carbodiimides23, SO3 in DMF24, 
Bi(OAc)325, Bi(OTf)326, Al2O327, Silica-supported 
heteropolyacids28, Ca(OAc)229, Supported-KF30, 
ZnCl231, Fe2O332, Al2O3-H3BO333, CDMT34 and ZnO35. 
Although all of these catalysed reactions 
 
Figure 1 — Selected example of azlactone moiety containing 
bioactive molecule 





demonstrated certain advantages, still some of the 
catalysed reaction suffered disadvantages including 
use of the expensive catalyst, hazardous reagent, more 
reaction step involving longer time, tedious workup 
and recovery of the catalyst. Continuing our efforts to 
develop simple and efficient synthetic protocol in 
bioactive molecule synthesis. Here, we wish to report 
simple practical procedure for the synthesis of 
azlactone by the condensation of aromatic aldehyde 
and hippuric acid in presence of acetic anhydride and 
heterogeneous catalyst zinc dust. 
Over the past few decades, the application of zinc 
dust in organic transformation is well exploited. Zinc 
dust has been utilized in various organic synthesis 
includes Williamson reaction36, Barbier reaction37, 
Diels-alder reaction38, Friedel-crafts sulfonylation39, 
Fries rearrangement40, acylation of phenols, 
thiophenols, amines and alcohols41, N-sulfonylation 
of amines42 and many more important chemical 
transformations43,44. Further, Zinc dust also been 
employed as an acid neutralizer in the synthesis of  
Z-amino acids45 and peptide synthesis employing 
Fmoc-amino acid chlorides46. 
 
Results and Discussion 
Azlactones are versatile and promising heterocyclic 
molecules, which are used in vast area of research 
fields. The molecule contains many reactive sites 
permit to synthesize wide range of interesting 
molecule and showed promising applications in 
chemical biology and material science. Present work, 
chosen zinc dust as heterogeneous catalyst which is 
inexpensive and non-toxic, and not been reported for 
the synthesis of azlactone as per our knowledge of 
literature. The synthetic method demonstrated simple, 
greener and efficient reaction protocol developed  
for the synthesis of 4-arylidine-2-phenyl-5(4H)-
oxazolones. One of the key building blocks for the 
azlactone synthesis is hippuric acid, which is 
synthesized by the reaction of benzoyl chloride and 
glycine in presence of base as depicted in Scheme I. 
After completion of the reaction, product isolated and 
recrystallized using hot water. To evaluate reaction 
conditions, we selected a model reaction of 
benzaldehyde (1mmol) with hippuric acid (1mmol) in 
the presence of Ac2O (3.3mmol) and zinc dust at RT 
(Scheme I). After stirring for several hours’, the 
product isolation found lesser yield of azlactone. This 
model experiment reaction gave us path to think of 
using organic solvent, and we have systematically 
optimized the reaction by employing several solvent 
available at our laboratory in a model reaction and  
the same is tabulated in Table I. To optimize  
suitable solvent the reaction carried out in a model 
reaction using different solvent system such  
as Chloroform (CHCl3), Dichloromethane (CH2Cl2), 
Acetonitrile (CH3CN), N,N-dimethylformamide (DMF), 
Methanol (MeOH), 1,4-dioxane, Ethanol (EtOH) and 
tetrahydrofuran (THF) at RT. The final isolated 
product revealed that, the reaction carried out in 
presence of ethanol emerged as a suitable solvent 
condition for this reaction and isolated product 78% 
























Scheme I — Synthesis of hippuric acid and azlactones 
 
Table I — Optimization of the solvent and catalyst 
Entry Solvent* Catalyst (mmol) Time (min) Yielda (%)
1 CHCl3 1 45 38 
2 CH2Cl2 1 40 40 
3 CH3CN 1 45 44 
4 THF 1 40 48 
5 MeOH 1 55 43 
6 DMF 1 60 32 
7 1,4-dioxane 1 70 30 
8 Neat 1 25 58d 
9 EtOH 1 35 78 
10 EtOH 2 15 91b,d 
11 EtOH 1 15 91d 
12 Neat 1 35 48 
13 EtOH 1.5 15 91c 
* Solvent employed (3mL). 
a Yields isolated 
b 2mmol of zinc dust employed for the reaction 
c 1.5mmol of zinc dust employed for the reaction 
d Reaction carried out at 60°C 





temperature on the rate of the reaction, the reaction is 
carried out by external heating near to boiling point of 
the solvent (60 °C), surprisingly the reaction at 60 °C 
completed within 15min as monitored by the TLC and 
isolated excellent yield up to 91% of the product 
(Table I). 
To validate the importance of the solvent required 
in the present protocol, reaction carried out in model 
reaction compared with solvent-free (Table I, entry 8) 
the reaction carried out in presence of ethanol gave 
high yield (Table I, entry 11) compare to solvent-free 
condition. Over all the above reactions revealed that 
reaction required presence of a catalyst and Ac2O with 
suitable solvent resulted efficient synthesis of 
azlactone. To check the optimal amount of zinc dust 
required for the catalysis, we examined series of 
reaction in a model reaction. The amount of zinc dust 
started 1mmol (66mg), 1.5 mmol and 2mmol of zinc 
dust (Table I). After reaction completion, the final 
product isolated revealed that, the reaction carried out 
in zinc dust, 1.5 and 2 mmol scale reaction not 
observed higher yield compare to 1mmolzinc dust 
used. Thus increased catalyst amount has no effect on 
the isolation of the higher product yield. From this 
experiment, we determined minimal amount of zinc 
dust required for the 1mmol scale reaction is 66mg 
(1mmol). To check the reaction compatibility and 
tolerance, various substituted benzaldehyde 
derivatives are subjected for the reaction. The method 
found to be tolerable to various substituted aromatic 
aldehyde gave moderate to excellent yields. To 
examine present protocol to alkyl aldehyde, the 
reaction is designed for the condensation of 
acetaldehyde with hippuric acid in presence of zinc 
dust at optimized condition at 1hr reflux resulted only 
24% yield of product isolation. A plausible 
mechanism has been depicted for the zinc dust 
catalysed synthesis of 4-arylidene-2-phenyl-5-(4H)-
oxazolones in Scheme II. The mechanism suggests 
that, initially the reaction proceeds via activating 
carbonyl group of acetic anhydride followed by 
nucleophilic addition of hippuric acid and cyclization 
takes place at oxygen centre eliminating acetic  
acid and water by forming 2-phenyl-5-oxazolone 
intermediate. Further, zinc dust is utilized in the 
deprotonating of formed intermediate, which 
produces oxazolone anion to which activated carbonyl 
compounds have been added to form the 
corresponding product. It seems that heating the 
reaction mixture accelerates the intermediate 
formation and therefore, accelerates the overall 
reaction accordingly. Pure product is obtained on 
recrystallizing the crude product using absolute 
alcohol, which is pure enough to collect spectral  
data without further purification like column 
chromatography (Table II). The homogeneity of the 
product 3a was confirmed by FT-IR, 1H-, 13C NMR 
spectroscopy and mass spectrometry analysis. The 
data shows characteristic peaks for FT-IR spectrum of 
product 3a at 1795.86 (CO), 1650.13 (C=N), 1563.43, 
1443.11, 1325.62, 1160.36, 762.75, 652.12, 1H NMR 
spectrum of product 3a exhibited characteristic singlet 
at 7.26 for 1 vinylic H, multiplet from 7.46 to 7.64 for 
5 aromatic hydrogens present on aldehydic ring, 
multiplet from 8.18 to 8.23 for 5 aromatic hydrogens 
present on oxazolone ring. Characteristic peaks for 
13C NMR are as follows 125.63, 128.40, 128.92, 
131.20, 131.80, 132.47, 133.36 and 133.54. HR-MS 
spectra shows m/z value at 250.0868 Da for 


























































Scheme II — Plausible mechanism for the zinc dust catalysed synthesis of 4-arylidene-2-phenyl-5-(4H)-oxazolones 





mainly focused on the establishment of simple, 
convenient and eco-friendly protocols to 
pharmacologically potent skeleton synthesis61-67. In the 
present study we have developed an efficient protocol 
for the synthesis of 4-arylidene-2-phenyl-5(4H)-
oxazolones in mild conditions. In order to show merits 
of the present approach, we have summarized some of 
the previous literature reports of 4-benzylidene-2-
phenyloxazol-5(4H)-one synthesis in Table III, which 
describes the merits of the present method like 
inexpensive catalyst, no hazardous solvent usage, 
shorter reaction time, easier workup, product isolation, 
good to excellent. Further, to check the compatibility  
of present method in multi gram scale synthesis,  
4-benzylidene-2-phenyloxazol-5(4H)-one chosen, 
synthesis by taking benzaldehyde (1.02mL, 10 mmol), 
hippuric acid (1.79gm, 10 mmol), Ac2O (3.3mL, 
33mmol), zinc dust (1gm) EtOH (15 mL). The reaction 
mixture refluxed at 60°C for 40 min, and monitored by 
TLC, after reaction completion, filtered to separate the 
catalyst cooled to RT, and washed with hot ethanol and 
recrystallized by absolute alcohol gave, product 
isolation of 84% yield. The separated catalyst washed 
in a suitable solvent, dried, and reused for at least two 
cycles of gram scale synthesis. The reaction found to 
be faster reaction, easier work up and resulted high 
yield of product isolation. 
 
Material and Methods 
Laboratory grade chemicals were purchased from 
commercial sources and used as received without 
further purification. Melting points were determined 
in open capillaries and are uncorrected. FT-IR spectra 
were recorded in KBr pellets on a Shimadzu 
spectrometer. 1H-, 13C NMR spectra were recorded on 
a Bruker400 MHz spectrometer using TMS as an 
internal standard. LC-MS spectra were recorded in 
Waters; Synapt G2 High detection Mass spectrometry 
and HR-MS spectra were recorded in Waters; 
XEVOG2 XS Q-TOF Mass spectrometry. The 
progress of the reaction monitored by TLC, yields 
referred to isolated pure products. 
Table II — Physical data of 4-arylidene-2-phenyl-5(4H)-oxazolones (3a-l) 
m.p. (°C) Entry Ar Time (min) Yield a (%) Product 
Found Reported 
1 C6H5 15 91 3a 167-169 16927 
2 4-ClC6H4 15 92 3b 188-190 19047 
3 4-OMeC6H4 20 91 3c 155-157 15447 
4 4-BrC6H4 20 88 3d 195-197 194-19548 
5 4-CH3C6H4 15 89 3e 168-169 167-16827 
6 4-FC6H4 20 87 3f 183-184 183-18527 
7 4-N(Me)2 C6H4 20 88 3g 212-214 212-21449 
8 4-NO2C6H4 15 89 3h 238-240 24147 
9 2-BrC6H4 22 87 3i 144-145 14449 
10 2-ClC6H4 20 89 3j 151-153 15347 
11 2-NO2C6H4 18 88 3k 163-164 164-16560 
12 3,4-(OMe)2 20 89 3l 151-153 152-15460 
a Yields refers to isolated yields 
 
Table III — Comparison of present method with different catalytic approaches reported to azlactone (3a) synthesis. 
Sl. No Catalyst Condition Time Yield (%) Ref. 
1 Iodine MW 65 sec 94 51 
2 Mg/Al2O3 MW 5 min 90 52 
3 K3PO4 80°C 30 min 93 53 
4 [C6CmIm)2]2W10O322H2O US, RT 24 min 85 54 
5 Ca(OAc)2 MW 5 min 97 55 
6 ZnO RT 10 min 90 37 
7 Fe2O3 nanoparticles US, RT 10 min 95 56 
8 [Bmim]3 PW12O40 80°C 75 min 89 57 
9 [Bmim]OH RT 90 min 87 58 
10 [Bmim]OH@agar RT 20 min 90 59 
11 Zinc dust 60°C 15 min 91 This work 
 







General procedure for the synthesis of azlactone derivatives 
In a dry 50 mL RB flask taken aldehyde (1 mmol), 
hippuric acid (1mmol), acetic anhydride (3.3 mmol) 
in EtOH (3mL) followed by Zinc dust (1 mmol). The 
mixture was stirred at 60°C temperature for 
appropriate time (Table I). TLC monitored the 
progress of the reaction. After completion of the 
reaction, hot ethanol was added, the catalyst separated 
by filtration, and final product obtained in pure form 
by recrystallization using absolute ethanol without 
using chromatography technique. 
 
Spectral data of representative compounds 
4-Benzylidene-2-phenyloxazol-5(4H)-one (Table II, 
3a): Yellow solid. Yield 92%. m.p. 167-169°C. FT-IR 
(KBr): 1795.86, 1650.13, 1563.43, 1443.11, 1325.62, 
1160.36, 762.75, 652.13 cm–1; 1H NMR (CDCl3): δ 
7.26 (s, 1H, -CH=), 7.46–7.64 (m, 5H, ArH), 8.18–
8.23 (m, 5H, ArH); 13C NMR (CDCl3): δ 125.63, 
128.40, 128.92, 131.20, 131.80, 132.47, 133.36, 
133.54; HR-MS: Calcd [M]+ 249.2650. Obsd m/z 
250.0992 (M+H)+ 
4-(4-Chlorobenzylidene)-2-phenyloxazol-5(4H)-one 
(Table II, 3b): Yellow solid. Yield 94%. m.p. 188-
190°C; FT-IR (KBr): 2917.74, 1795.06, 1767.50, 
1652.82, 1582.56, 1484.27, 1327.73, 1300.07, 
1161.15, 1070.72, 835.91 cm–1; 1H NMR (CDCl3): δ  
7.18 (1H, s), 7.45 (d, 2H), 7.51-7.62 (m, 3H), 8.14 (d, 
2H), 8.14 – 8.17 (m, 2H); 13C NMR (CDCl3): δ 
125.44, 128.44, 128.98, 129.23, 130.01, 131.77, 
132.01, 133.50, 137.27, 163.90, 167.35; LC-MS 
Calcd [M]+ 283.7091. Obsd m/z 284.0388(M+H)+. 
4-(4-Methoxybenzylidene)-2-phenyloxazol-5(4H)-
one (Table II, 3c): Orange solid. Yield 93%. m.p. 
155-157°C; FT-IR (KBr): 2843.99, 1788.70, 1653.50, 
1599.46, 1512.08, 1487.83, 1111.72, 924.55, 861.95 
cm–1; 1H NMR (CDCl3): δ 3.87 (s, 3H), 6.95-6.99 (d, 
2H, J = 8.8 Hz), 7.26 (1H, s), 7.43 – 7.57 (m, 3H), 
8.18 – 8.19 (m, 2H), 8.21 (d, 2H, J = 8.8 Hz); 
13C NMR (CDCl3): δ 55.56, 113.74, 114.53, 127.06, 
128.1, 128.8, 131.8, 132.31, 134.58, 162.2, 167.9; 
LC-MS: Calcd [M]+ 279.2900. Obsd m/z 280.0536 
[M+H]+. 
4-(4-Bromobenzylidene)-2-phenyloxazol-5(4H)-one, 
(Table II, 3d): Yellow solid. Yield 90%. m.p. 195-
197°C; FT-IR (KBr): 3418.49, 2389.63, 1767.50, 
1652.82, 1582.56, 1484.39, 1326.25, 1237.73, 
1161.15, 1108.49, 835.91 cm–1; 1H NMR (CDCl3): δ 
7.17 (1H, s), 7.25 (d, 2H), 7.52 - 7.65 (m, 3H), 8.06 - 
8.08 (d, 2H), 8.17 – 8.19 (m, 2H); 13C NMR (CDCl3): 
δ 125.45, 125.90, 128.47, 129.09, 130.08, 131.77, 
132.22, 133.64, 133.79, 163.97, 167.35 ; LC-MS: 
Calcd [M]+ 328.1601. Obsd m/z 328.9163 [M+H]+. 
 
Conclusion 
We have demonstrated a simple, convenient and 
efficient approach for the synthesis of 4-arylidene-2-
phenyl-5(4H)-oxazolones from the condensation of 
arylaldehydes, and hippuric acid catalysed by 
heterogeneous zinc dust catalyst. The method is 
tolerable to various substituted aromatic aldehydes. 
The present approach has several merits over reported 
protocols like in-expensive catalyst, eco-friendly 
approach, easy workup, good to excellent yield 
isolation and shorter reaction times. The crude final 
product is easily recrystallized using absolute alcohol 
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